标题
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
作者
关键词
-
出版物
PHARMACOLOGICAL RESEARCH
Volume 182, Issue -, Pages 106320
出版商
Elsevier BV
发表日期
2022-06-21
DOI
10.1016/j.phrs.2022.106320
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
- (2022) C. Meurot et al. Scientific Reports
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Matthias von Herrath et al. Lancet Diabetes & Endocrinology
- Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials
- (2021) Jonathan J. H. Bray et al. DIABETES OBESITY & METABOLISM
- Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH
- (2021) Katharina Luise Hupa-Breier et al. Biomedicines
- Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist
- (2021) Rayane Miranda Pontes-da-Silva et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
- (2021) Valentina Guarnotta et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy
- (2021) Lingli Zhou et al. JCI Insight
- Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
- (2020) Ana I. Duarte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preventive Effects of Dulaglutide on Disuse Muscle Atrophy Through Inhibition of Inflammation and Apoptosis by Induction of Hsp72 Expression
- (2020) Tram Thi Ngoc Nguyen et al. Frontiers in Pharmacology
- Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats
- (2020) Rania G. Abdel-latif et al. LIFE SCIENCES
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System
- (2019) Hsin-Ying Chiou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway
- (2019) Zhi Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
- (2019) Philip Newsome et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
- (2019) Helena W. Rodbard et al. DIABETES CARE
- Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation
- (2019) Foteini Moschovaki Filippidou et al. AMERICAN JOURNAL OF PATHOLOGY
- Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages
- (2019) Canrong Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
- (2019) Habib Yaribeygi et al. LIFE SCIENCES
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- Glucagon-like peptide-1 receptor expression in the human eye
- (2018) Josephine B. Hebsgaard et al. DIABETES OBESITY & METABOLISM
- Liraglutide, a Glucagon-Like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model
- (2018) Zhi-Min Wang et al. TRANSPLANTATION
- Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
- (2018) Jordan Rowlands et al. Frontiers in Endocrinology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improvement of islet graft function using liraglutide is correlated with its anti-inflammatory properties
- (2016) A Langlois et al. BRITISH JOURNAL OF PHARMACOLOGY
- iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy
- (2016) Lydia Lynch et al. Cell Metabolism
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner
- (2016) Łukasz Bułdak et al. Pharmacological Reports
- Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
- (2016) Line S. Bisgaard et al. PLoS One
- Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix
- (2015) Emma Robinson et al. BASIC RESEARCH IN CARDIOLOGY
- GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
- (2015) Bernardo Yusta et al. DIABETES
- Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice
- (2015) Serap Sancar-Bas et al. GROWTH FACTORS
- Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study
- (2015) Manfredi Rizzo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular Actions of Incretin-Based Therapies
- (2014) John R. Ussher et al. CIRCULATION RESEARCH
- Simultaneous GLP-1 and Insulin Administration Acutely Enhances Their Vasodilatory, Antiinflammatory, and Antioxidant Action in Type 2 Diabetes
- (2014) Antonio Ceriello et al. DIABETES CARE
- IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
- (2014) Kimberly A. Negrin et al. PLoS One
- Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration
- (2013) Y Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes
- (2013) Lan He et al. Journal of Diabetes Investigation
- Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes
- (2012) Y.-S. Lee et al. DIABETOLOGIA
- Anti-Inflammatory Properties of Exenatide in Human Pancreatic Islets
- (2011) S. R. Cechin et al. CELL TRANSPLANTATION
- Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis
- (2011) A. E. Hogan et al. DIABETOLOGIA
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Exenatide Exerts a Potent Antiinflammatory Effect
- (2011) Ajay Chaudhuri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
- (2010) I. Hadjiyanni et al. DIABETOLOGIA
- Exendin-4 Protects -Cells From Interleukin-1 -Induced Apoptosis by Interfering With the c-Jun NH2-Terminal Kinase Pathway
- (2008) M. Ferdaoussi et al. DIABETES
- Exendin-4 Modulates Diabetes Onset in Nonobese Diabetic Mice
- (2007) Irene Hadjiyanni et al. ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started